Chai Discovery
PulseAugur coverage of Chai Discovery — every cluster mentioning Chai Discovery across labs, papers, and developer communities, ranked by signal.
- 2026-08-11 product_launch Chai Discovery is shifting focus to providing AI tools for drug design, highlighted by deals at the JPM Pharma conference. source
- 2026-07-14 funding Chai Discovery, an AI drug discovery startup, raised $400 million. source
- 2026-06-04 partnership Chai Discovery has signed new drug development partnerships with Pfizer and Eli Lilly, leveraging its AI models. source
1 day(s) with sentiment data
-
Chai Discovery fuels AI-driven drug design shift with new pharma tools
Chai Discovery, an AI company backed by OpenAI, is at the forefront of a significant shift in the pharmaceutical industry, moving from drug development to providing AI tools for drug design. This transition was highligh…
-
Chai Discovery: Biology is becoming programmable like software
Chai Discovery co-founders Matt McPartland and Neil Patel discuss the increasing digitization of biology, likening it to the transformation of software development. They highlight how biological processes are becoming m…
-
Ex-OpenAI Researcher's AI Drug Startup Nears $2B Valuation
A former OpenAI researcher, Miles Wang, has left the company to co-found an AI drug discovery startup, which is reportedly in talks for a $200 million funding round at a $2 billion valuation. This move highlights a grow…
-
OpenAI Researcher Eyes $2B Valuation for AI Drug Discovery Startup
Miles Wang, a researcher from OpenAI, is reportedly in discussions to launch a new startup focused on AI-driven drug discovery. The venture is aiming to secure approximately $200 million in funding at a valuation of $2 …
-
AI Drug Discovery Startup Chai Discovery Secures $400 Million
Chai Discovery, a startup focused on using artificial intelligence for drug development, has successfully raised $400 million in a funding round. The company aims to leverage AI to accelerate the process of discovering …
-
Chai Discovery: AI Platform for Advanced Drug and Antibody Design
Chai Discovery is presented as a leading AI platform for drug discovery, antibody design, and biomolecular prediction. The review covers its features, pricing, and pros and cons, aiming to explore its capabilities beyon…
-
SpaceX eyes healthcare with Starlink, orbital drug manufacturing, and AI
SpaceX is exploring multiple avenues into the healthcare sector, leveraging its Starlink satellite internet service to improve remote healthcare access in underserved regions. The company also plans to manufacture pharm…
-
AI drug discovery firm Chai lands deals with Pfizer and Eli Lilly
Chai Discovery, an AI drug discovery startup, has secured significant partnerships with pharmaceutical giants Eli Lilly and Pfizer. The company's advanced antibody design models, including the recently deployed Chai-3, …
-
AI cloud platform Modal raises $355M at $4.65B valuation
Modal has secured $355 million in Series C funding, valuing the company at $4.65 billion post-money. The company has experienced significant growth, with annualized revenue surpassing $300 million and a fivefold increas…